Jayatma Industries Limited (BOM:531323)
14.47
-0.76 (-4.99%)
At close: Aug 1, 2025
Revance Therapeutics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 7.62 | 7.85 | 17.37 | 1.22 | 30.75 | Upgrade |
Cash & Short-Term Investments | 7.62 | 7.85 | 17.37 | 1.22 | 30.75 | Upgrade |
Cash Growth | -2.97% | -54.80% | 1324.86% | -96.04% | 1154.47% | Upgrade |
Accounts Receivable | 40.04 | 29.75 | 225.4 | 153.29 | 204.73 | Upgrade |
Other Receivables | - | 2.57 | 3.54 | 2.33 | 11.62 | Upgrade |
Receivables | 40.04 | 32.32 | 228.94 | 155.61 | 216.35 | Upgrade |
Inventory | 144.95 | 122.9 | 47.8 | 57.83 | 50.1 | Upgrade |
Prepaid Expenses | - | - | - | - | 0.27 | Upgrade |
Other Current Assets | 38.67 | 23.27 | 20.87 | 29.76 | 5.85 | Upgrade |
Total Current Assets | 231.29 | 186.34 | 314.98 | 244.43 | 303.32 | Upgrade |
Property, Plant & Equipment | 77.6 | 83.53 | 52.72 | 40.42 | 43.6 | Upgrade |
Long-Term Investments | 1.23 | 1.19 | 2.13 | 2.05 | 0.76 | Upgrade |
Other Long-Term Assets | 0 | 0 | -0 | 0 | 3.1 | Upgrade |
Total Assets | 312.13 | 273.73 | 373.11 | 290.05 | 350.78 | Upgrade |
Accounts Payable | 0.92 | 4.63 | 9.6 | 17.95 | 57.25 | Upgrade |
Accrued Expenses | - | - | - | - | 3.4 | Upgrade |
Current Portion of Long-Term Debt | 66.25 | 92.76 | 196.21 | 109.82 | 132.81 | Upgrade |
Current Income Taxes Payable | - | - | - | - | 3.44 | Upgrade |
Other Current Liabilities | 6.23 | 4.79 | 19.01 | 8.01 | 1.91 | Upgrade |
Total Current Liabilities | 73.41 | 102.18 | 224.83 | 135.78 | 198.81 | Upgrade |
Long-Term Debt | 127.19 | 41.52 | 19.08 | 25.89 | 26.02 | Upgrade |
Long-Term Deferred Tax Liabilities | 7.47 | 6.94 | 6.75 | 6.95 | 7.21 | Upgrade |
Other Long-Term Liabilities | - | - | - | 0 | 0 | Upgrade |
Total Liabilities | 208.07 | 150.64 | 250.67 | 168.63 | 232.03 | Upgrade |
Common Stock | 61.53 | 61.53 | 61.53 | 61.53 | 61.53 | Upgrade |
Additional Paid-In Capital | - | 38.38 | 38.38 | 38.38 | 38.38 | Upgrade |
Retained Earnings | - | 19.84 | 19.19 | 18.17 | 15.49 | Upgrade |
Comprehensive Income & Other | 42.53 | 3.35 | 3.35 | 3.35 | 3.35 | Upgrade |
Shareholders' Equity | 104.06 | 123.1 | 122.44 | 121.42 | 118.75 | Upgrade |
Total Liabilities & Equity | 312.13 | 273.73 | 373.11 | 290.05 | 350.78 | Upgrade |
Total Debt | 193.44 | 134.28 | 215.3 | 135.71 | 158.83 | Upgrade |
Net Cash (Debt) | -185.82 | -126.43 | -197.93 | -134.49 | -128.08 | Upgrade |
Net Cash Per Share | -30.24 | -20.48 | -32.06 | -21.78 | -20.74 | Upgrade |
Filing Date Shares Outstanding | 6.16 | 6.17 | 6.17 | 6.17 | 6.17 | Upgrade |
Total Common Shares Outstanding | 6.16 | 6.17 | 6.17 | 6.17 | 6.17 | Upgrade |
Working Capital | 157.88 | 84.16 | 90.15 | 108.64 | 104.51 | Upgrade |
Book Value Per Share | 16.90 | 19.94 | 19.83 | 19.67 | 19.23 | Upgrade |
Tangible Book Value | 104.06 | 123.1 | 122.44 | 121.42 | 118.75 | Upgrade |
Tangible Book Value Per Share | 16.90 | 19.94 | 19.83 | 19.67 | 19.23 | Upgrade |
Land | - | 1.87 | 1.87 | 1.87 | 1.87 | Upgrade |
Buildings | - | 26.15 | 18.32 | 18.32 | 18.32 | Upgrade |
Machinery | - | 100.3 | 72.13 | 57.36 | 58.31 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.